Title: Principles Underlying the Development and Use of Live Attenuated Cold-Adapted Influenza A and B Virus Vaccines
Abstract: Viral ImmunologyVol. 15, No. 2 Principles Underlying the Development and Use of Live Attenuated Cold-Adapted Influenza A and B Virus VaccinesBrian R. Murphy and Kathleen CoelinghBrian R. Murphy and Kathleen CoelinghPublished Online:9 Jul 2004https://doi.org/10.1089/08828240260066242AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byIntranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults9 November 2022 | The Journal of Infectious Diseases, Vol. 227, No. 1Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunityiScience, Vol. 25, No. 11Next generation live-attenuated influenza vaccine platforms5 May 2022 | Expert Review of Vaccines, Vol. 21, No. 8Live Attenuated Cold-Adapted Influenza Vaccines6 April 2020 | Cold Spring Harbor Perspectives in Medicine, Vol. 11, No. 9Could live attenuated vaccines better control COVID-19?Vaccine, Vol. 39, No. 39A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines30 June 2021 | Viruses, Vol. 13, No. 7Selecting and Using the Appropriate Influenza Vaccine for Each Individual24 May 2021 | Viruses, Vol. 13, No. 6Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain Using an Engineered High-Fidelity Viral PolymeraseJournal of Virology, Vol. 95, No. 12Influenza Vaccines20 August 2021Live Attenuated Influenza Vaccines for Pandemic Preparedness19 March 2020 | Journal of the Pediatric Infectious Diseases Society, Vol. 9, No. Supplement_1Why are vaccines against many human viral diseases still unavailable; an historic perspective?3 October 2019 | Journal of Medical Virology, Vol. 92, No. 2Immunogenicity and Protective Efficacy of Seasonal Human Live Attenuated Cold-Adapted Influenza Virus Vaccine in Pigs8 November 2019 | Frontiers in Immunology, Vol. 10Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza VaccinesmBio, Vol. 10, No. 5Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines10 October 2019 | Viruses, Vol. 11, No. 10How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines8 April 2019 | The Journal of Infectious Diseases, Vol. 219, No. Supplement_1Novel Approaches for The Development of Live Attenuated Influenza Vaccines22 February 2019 | Viruses, Vol. 11, No. 2Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccinesVirology, Vol. 522Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunityVaccine, Vol. 36, No. 33Preparation and evaluation of a novel, live, attenuated influenza H1N1 vaccine strain produced by a modified classical reassortment method31 October 2017 | Human Vaccines & Immunotherapeutics, Vol. 14, No. 3Development of a novel equine influenza virus live-attenuated vaccineVirology, Vol. 516Influenza Vaccine—LivePerspectives from the Society for Pediatric Research: Decreased Effectiveness of the Live Attenuated Influenza Vaccine8 November 2017 | Pediatric Research, Vol. 83, No. 1Live Attenuated Influenza Vaccine contains Substantial and Unexpected Amounts of Defective Viral Genomic RNA21 September 2017 | Viruses, Vol. 9, No. 10Genotyping assay for differentiation of wild-type and vaccine viruses in subjects immunized with live attenuated influenza vaccine7 July 2017 | PLOS ONE, Vol. 12, No. 7Creation of live influenza vaccines with the use of site-specific mutagenesis23 August 2017 | Biology Bulletin Reviews, Vol. 7, No. 4A live-attenuated influenza vaccine for H3N2 canine influenza virusVirology, Vol. 504Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 VaccineJournal of Virology, Vol. 91, No. 4Influenza Vaccines3 November 2017Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic VirusJournal of Virology, Vol. 90, No. 19Development of a stable liquid formulation of live attenuated influenza vaccineVaccine, Vol. 34, No. 32Evaluating influenza vaccines: progress and perspectivesFuture Virology, Vol. 11, No. 5Enhancement of the safety of live influenza vaccine by attenuating mutations from cold-adapted hemagglutininVirology, Vol. 491Genetic analysis of attenuation markers of cold-adapted X-31 influenza live vaccine donor strainVaccine, Vol. 34, No. 11Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor virusesJournal of Virological Methods, Vol. 227Attenuation of the influenza virus by microRNA response element in vivo and protective efficacy against 2009 pandemic H1N1 virus in miceInternational Journal of Infectious Diseases, Vol. 38A live attenuated vaccine prevents replication and transmission of H7N9 virus in mammals10 June 2015 | Scientific Reports, Vol. 5, No. 1Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cellsVaccine, Vol. 33, No. 36Adenoviral vectors as novel vaccines for influenza5 January 2015 | Journal of Pharmacy and Pharmacology, Vol. 67, No. 3A Live Attenuated Equine H3N8 Influenza Vaccine Is Highly Immunogenic and Efficacious in Mice and FerretsJournal of Virology, Vol. 89, No. 3Influenza (Including Avian Influenza and Swine Influenza)The Matrix Gene Segment Destabilizes the Acid and Thermal Stability of the Hemagglutinin of Pandemic Live Attenuated Influenza Virus VaccinesJournal of Virology, Vol. 88, No. 21Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms23 May 2014 | Expert Review of Vaccines, Vol. 13, No. 7Development of a High-Yield Live Attenuated H7N9 Influenza Virus Vaccine That Provides Protection against Homologous and Heterologous H7 Wild-Type Viruses in FerretsJournal of Virology, Vol. 88, No. 12Production of live attenuated influenza vaccines against seasonal and potential pandemic influenza virusesCurrent Opinion in Virology, Vol. 6Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators10 April 2014 | Vaccines, Vol. 2, No. 2Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell culturesVaccine, Vol. 32, No. 15Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine productionJournal of Virological Methods, Vol. 195Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strainsVaccine, Vol. 32, No. 5New vaccines against influenza virusClinical and Experimental Vaccine Research, Vol. 3, No. 1Live Attenuated Influenza Vaccine25 July 2014H5N1 vaccines in humansVirus Research, Vol. 178, No. 1Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2–6 years in Germany24 October 2013 | Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, Vol. 56, No. 11Evaluation of Live Attenuated H7N3 and H7N7 Vaccine Viruses for Their Receptor Binding Preferences, Immunogenicity in Ferrets and Cross Reactivity to the Novel H7N9 Virus9 October 2013 | PLoS ONE, Vol. 8, No. 10An Eight-Segment Swine Influenza Virus Harboring H1 and H3 Hemagglutinins Is Attenuated and Protective against H1N1 and H3N2 Subtypes in PigsJournal of Virology, Vol. 87, No. 18WITHDRAWN: Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine productionJournal of Virological MethodsImmunogenicity and protective efficacy of cold-adapted X-31 live attenuated pre-pandemic H5N1 influenza vaccinesVaccine, Vol. 31, No. 33Identification of Critical Residues in the Hemagglutinin and Neuraminidase of Influenza Virus H1N1pdm for Vaccine Virus Replication in Embryonated Chicken EggsJournal of Virology, Vol. 87, No. 8Molecular Basis of Live-Attenuated Influenza Virus26 March 2013 | PLoS ONE, Vol. 8, No. 3Immunobiology of Influenza VaccinesChest, Vol. 143, No. 2Influenza vaccine—liveTargeted Vaccine Selection in Influenza Vaccination22 November 2013 | Deutsches Ärzteblatt internationalDevelopment of Live-Attenuated Influenza Vaccines against Outbreaks of H5N1 Influenza10 December 2012 | Viruses, Vol. 4, No. 12Comparative Study of Influenza Virus Replication in MDCK Cells and in Primary Cells Derived from Adenoids and Airway EpitheliumJournal of Virology, Vol. 86, No. 21Quadrivalent Ann Arbor strain live-attenuated influenza vaccine9 January 2014 | Expert Review of Vaccines, Vol. 11, No. 11Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in ChildrenPediatric Infectious Disease Journal, Vol. 31, No. 7Evaluation of Influenza Virus A/H3N2 and B Vaccines on the Basis of Cross-Reactivity of Postvaccination Human Serum Antibodies against Influenza Viruses A/H3N2 and B Isolated in MDCK Cells and Embryonated Hen Eggs4 April 2012 | Clinical and Vaccine Immunology, Vol. 19, No. 6Engineering temperature sensitive live attenuated influenza vaccines from emerging virusesVaccine, Vol. 30, No. 24The Receptor Binding Specificity of the Live Attenuated Influenza H2 and H6 Vaccine Viruses Contributes to Vaccine Immunogenicity and Protection in FerretsJournal of Virology, Vol. 86, No. 5Generation of recombinant pandemic H1N1 influenza virus with the HA cleavable by bromelain and identification of the residues influencing HA bromelain cleavageVaccine, Vol. 30, No. 5Principles underlying rational design of live attenuated influenza vaccinesClinical and Experimental Vaccine Research, Vol. 1, No. 1Novel vaccines against influenza virusesVirus Research, Vol. 162, No. 1-2Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferretsVaccine, Vol. 29, No. 49A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adultsVaccine, Vol. 29, No. 50Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference9 January 2014 | Expert Review of Vaccines, Vol. 10, No. 8Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice15 July 2011 | PLoS ONE, Vol. 6, No. 7Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6–59 months of ageVaccine, Vol. 29, No. 26Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2)Virology, Vol. 412, No. 2Influenza Virus: The Biology of a Changing Virus22 September 2010The Role of Animal Models In Influenza Vaccine Research22 September 2010Live Attenuated Influenza Vaccine22 September 2010Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in Mice and FerretsVaccine, Vol. 29, No. 4Innovative bioinformatic approaches for developing peptide‐based vaccines against hypervariable viruses11 May 2010 | Immunology & Cell Biology, Vol. 89, No. 1Live Attenuated Vaccines: Influenza, Rotavirus and Varicella Zoster Virus29 September 2010Human influenza vaccines and assessment of immunogenicity9 January 2014 | Expert Review of Vaccines, Vol. 9, No. 12Glycosylation at 158N of the Hemagglutinin Protein and Receptor Binding Specificity Synergistically Affect the Antigenicity and Immunogenicity of a Live Attenuated H5N1 A/Vietnam/1203/2004 Vaccine Virus in FerretsJournal of Virology, Vol. 84, No. 13The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody responseVaccine, Vol. 28, No. 24Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferretsVirology, Vol. 398, No. 1Influenza Vaccines: From Surveillance Through Production to ProtectionMayo Clinic Proceedings, Vol. 85, No. 3The Development of Live-Attenuated Vaccines for Pandemic Influenza1 June 2010Influenza Viruses, Including Avian Influenza and Swine InfluenzaInfluenza28 February 2013Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A virusesVaccine, Vol. 27, No. 47Immunogenicity and Protective Efficacy of a Live Attenuated H5N1 Vaccine in Nonhuman Primates1 May 2009 | PLoS Pathogens, Vol. 5, No. 5A Live Attenuated H9N2 Influenza Vaccine Is Well Tolerated and Immunogenic in Healthy Adults1 March 2009 | Journal of Infectious Diseases, Vol. 199, No. 5Influenza Virus-Like Particles as Pandemic Vaccines4 August 2009Live Attenuated Vaccines for Pandemic Influenza4 August 2009Evaluation of Live Attenuated Influenza A Virus H6 Vaccines in Mice and FerretsJournal of Virology, Vol. 83, No. 1Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza8 December 2008 | Influenza and Other Respiratory Viruses, Vol. 2, No. 6Influenza B Virus NS1-Truncated Mutants: Live-Attenuated Vaccine ApproachJournal of Virology, Vol. 82, No. 21Molecular studies of temperature-sensitive replication of the cold-adapted B/Ann Arbor/1/66, the master donor virus for live attenuated influenza FluMist® vaccinesVirology, Vol. 380, No. 2Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of ageVaccine, Vol. 26, No. 38A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferretsVirology, Vol. 378, No. 1Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: Cold-adapted vaccine versus DNA prime-adenovirus boost strategiesVaccine, Vol. 26, No. 17Emerging vaccines for influenza5 March 2008 | Expert Opinion on Emerging Drugs, Vol. 13, No. 1Development and characterization of a live attenuated influenza B virus vaccine candidateVaccine, Vol. 26, No. 7The role of animal models in influenza vaccine researchLive attenuated influenza vaccineStabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggsVaccine, Vol. 26, No. 3Flu Myths: Dispelling the Myths Associated With Live Attenuated Influenza VaccineMayo Clinic Proceedings, Vol. 83, No. 1Toxicological evaluation of live attenuated, cold-adapted H5N1 vaccines in ferretsVaccine, Vol. 25, No. 52Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccineVaccine, Vol. 25, No. 47Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strainVirology, Vol. 367, No. 2Biophysical characterization of influenza virus subpopulations using field flow fractionation and multiangle light scattering: Correlation of particle counts, size distribution and infectivityJournal of Virological Methods, Vol. 144, No. 1-2Emerging Respiratory Viruses: Challenges and Vaccine StrategiesClinical Microbiology Reviews, Vol. 19, No. 4A Randomized, Double-Blind Study of the Safety, Transmissibility and Phenotypic and Genotypic Stability of Cold-Adapted Influenza Virus VaccinePediatric Infectious Disease Journal, Vol. 25, No. 7CD4 + T‐cell memory: generation and multi‐faceted roles for CD4 + T cells in protective immunity to influenza13 June 2006 | Immunological Reviews, Vol. 211, No. 1Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care settingVirology, Vol. 347, No. 2Genetic stability of live, cold-adapted influenza virus components of the FluMist®/CAIV-T vaccine throughout the manufacturing processVaccine, Vol. 24, No. 12Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist®)Virology, Vol. 345, No. 2The Pandemic Threat of Avian Influenza VirusesMaking Better Influenza Virus Vaccines?1 January 2006 | Emerging Infectious Diseases, Vol. 12, No. 1Vaccines for Pandemic Influenza1 January 2006 | Emerging Infectious Diseases, Vol. 12, No. 1Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeysVaccine, Vol. 23, No. 38Live-attenuated intranasal parainfluenza virus type 2 vaccine candidates developed by reverse genetics containing L polymerase protein mutations imported from heterologous paramyxovirusesVaccine, Vol. 23, No. 39Multiple Gene Segments Control the Temperature Sensitivity and Attenuation Phenotypes of ca B/Ann Arbor/1/66Journal of Virology, Vol. 79, No. 17Improvement of Influenza A/Fujian/411/02 (H3N2) Virus Growth in Embryonated Chicken Eggs by Balancing the Hemagglutinin and Neuraminidase Activities, Using Reverse GeneticsJournal of Virology, Vol. 79, No. 11Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortantsVirus Research, Vol. 105, No. 2The effect of influenza B virus M segment on the replication of reassortant vaccine virusesInternational Congress Series, Vol. 1263Molecular basis for temperature sensitivity and attenuation of the human vaccine strain ca B/Ann Arbor/1/66International Congress Series, Vol. 1263A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine modelVaccine, Vol. 22, No. 17-18Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine componentsMicrobes and Infection, Vol. 6, No. 6Imparting Temperature Sensitivity and Attenuation in Ferrets to A/Puerto Rico/8/34 Influenza Virus by Transferring the Genetic Signature for Temperature Sensitivity from Cold-Adapted A/Ann Arbor/6/60Journal of Virology, Vol. 78, No. 2Influenza Vaccines Generated by Reverse GeneticsInfluenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza VaccinesScandinavian Journal of Immunology, Vol. 59, No. 1Role of Influenza Vaccine For Healthy Children in the USPediatric Drugs, Vol. 6, No. 4Control of influenza virus infection by immunity to conserved viral features10 January 2014 | Expert Review of Anti-infective Therapy, Vol. 1, No. 4Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (flumist) derived from cold-adapted a/ann arbor/6/60Virology, Vol. 306, No. 1 Volume 15Issue 2Jun 2002 To cite this article:Brian R. Murphy and Kathleen Coelingh.Principles Underlying the Development and Use of Live Attenuated Cold-Adapted Influenza A and B Virus Vaccines.Viral Immunology.Jun 2002.295-323.http://doi.org/10.1089/08828240260066242Published in Volume: 15 Issue 2: July 9, 2004PDF download